UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: Sobril-10mg-Tablet-SE-IS-MPD

Generated Narrative: MedicinalProductDefinition Sobril-10mg-Tablet-SE-IS-MPD

identifier: http://ema.europa.eu/fhir/mpId/SE-100001390-00008880, http://ema.europa.eu/fhir/eurdId/2234

domain: Human use

status: Current

combinedPharmaceuticalDoseForm: Tablet

indication:

Sobril påverkar de vid ångestsyndrom vanliga symtomen: ängslan, ångest, rastlöshet och sömnsvårigheter. Vid depressioner med inslag av nyss nämnda symtom kan Sobril användas tillsammans med sedvanliga antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom som ångest, spänning och excitation i samband med alkoholmissbruk.

legalStatusOfSupply: Medicinal product subject to special medical prescription

classification: N05BA04

name

productName: Sobril® 10 mg Tablett

part

part: Sobril®

type: Invented name part

part

part: 10 mg

type: Strength part

part

part: Tablett

type: Pharmaceutical dose form part

Usages

-CountryLanguage
*Kingdom of SwedenSwedish